BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

541 related articles for article (PubMed ID: 17511970)

  • 41. Role of the basolateral amygdala in mediating the effects of the fatty acid amide hydrolase inhibitor URB597 on HPA axis response to stress.
    Bedse G; Colangeli R; Lavecchia AM; Romano A; Altieri F; Cifani C; Cassano T; Gaetani S
    Eur Neuropsychopharmacol; 2014 Sep; 24(9):1511-23. PubMed ID: 25106694
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The fatty acid amide hydrolase inhibitor, URB597, promotes retinal ganglion cell neuroprotection in a rat model of optic nerve axotomy.
    Slusar JE; Cairns EA; Szczesniak AM; Bradshaw HB; Di Polo A; Kelly ME
    Neuropharmacology; 2013 Sep; 72():116-25. PubMed ID: 23643752
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Brain permeant and impermeant inhibitors of fatty-acid amide hydrolase suppress the development and maintenance of paclitaxel-induced neuropathic pain without producing tolerance or physical dependence in vivo and synergize with paclitaxel to reduce tumor cell line viability in vitro.
    Slivicki RA; Xu Z; Mali SS; Hohmann AG
    Pharmacol Res; 2019 Apr; 142():267-282. PubMed ID: 30739035
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antidepressant effect of Chaihu-Shugan-San extract and its constituents in rat models of depression.
    Kim SH; Han J; Seog DH; Chung JY; Kim N; Hong Park Y; Lee SK
    Life Sci; 2005 Jan; 76(11):1297-306. PubMed ID: 15642599
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Analgesic effects of fatty acid amide hydrolase inhibition in a rat model of neuropathic pain.
    Jhaveri MD; Richardson D; Kendall DA; Barrett DA; Chapman V
    J Neurosci; 2006 Dec; 26(51):13318-27. PubMed ID: 17182782
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of repeated systemic administration of selective inhibitors of endocannabinoid inactivation on rat brain endocannabinoid levels.
    de Lago E; Petrosino S; Valenti M; Morera E; Ortega-Gutierrez S; Fernandez-Ruiz J; Di Marzo V
    Biochem Pharmacol; 2005 Aug; 70(3):446-52. PubMed ID: 15963472
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The novel neuropeptide Y Y5 receptor antagonist Lu AA33810 [N-[[trans-4-[(4,5-dihydro[1]benzothiepino[5,4-d]thiazol-2-yl)amino]cyclohexyl]methyl]-methanesulfonamide] exerts anxiolytic- and antidepressant-like effects in rat models of stress sensitivity.
    Walker MW; Wolinsky TD; Jubian V; Chandrasena G; Zhong H; Huang X; Miller S; Hegde LG; Marsteller DA; Marzabadi MR; Papp M; Overstreet DH; Gerald CP; Craig DA
    J Pharmacol Exp Ther; 2009 Mar; 328(3):900-11. PubMed ID: 19098165
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inhibition of anandamide hydrolysis enhances noradrenergic and GABAergic transmission in the prefrontal cortex and basolateral amygdala of rats subjected to acute swim stress.
    Bedse G; Romano A; Tempesta B; Lavecchia MA; Pace L; Bellomo A; Duranti A; Micioni Di Bonaventura MV; Cifani C; Cassano T; Gaetani S
    J Neurosci Res; 2015 May; 93(5):777-87. PubMed ID: 25581607
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Design, synthesis, and in vitro evaluation of carbamate derivatives of 2-benzoxazolyl- and 2-benzothiazolyl-(3-hydroxyphenyl)-methanones as novel fatty acid amide hydrolase inhibitors.
    Myllymäki MJ; Saario SM; Kataja AO; Castillo-Melendez JA; Nevalainen T; Juvonen RO; Järvinen T; Koskinen AM
    J Med Chem; 2007 Aug; 50(17):4236-42. PubMed ID: 17665899
    [TBL] [Abstract][Full Text] [Related]  

  • 50. On the mechanism of antidepressant-like action of berberine chloride.
    Kulkarni SK; Dhir A
    Eur J Pharmacol; 2008 Jul; 589(1-3):163-72. PubMed ID: 18585703
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Beneficial Changes in Rat Vascular Endocannabinoid System in Primary Hypertension and under Treatment with Chronic Inhibition of Fatty Acid Amide Hydrolase by URB597.
    Baranowska-Kuczko M; Kozłowska H; Kloza M; Harasim-Symbor E; Biernacki M; Kasacka I; Malinowska B
    Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34063297
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Fatty acid amide hydrolase inhibitors display broad selectivity and inhibit multiple carboxylesterases as off-targets.
    Zhang D; Saraf A; Kolasa T; Bhatia P; Zheng GZ; Patel M; Lannoye GS; Richardson P; Stewart A; Rogers JC; Brioni JD; Surowy CS
    Neuropharmacology; 2007 Mar; 52(4):1095-105. PubMed ID: 17217969
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Interactions between environmental aversiveness and the anxiolytic effects of enhanced cannabinoid signaling by FAAH inhibition in rats.
    Haller J; Barna I; Barsvari B; Gyimesi Pelczer K; Yasar S; Panlilio LV; Goldberg S
    Psychopharmacology (Berl); 2009 Jul; 204(4):607-16. PubMed ID: 19259645
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hypertension and chronic inhibition of endocannabinoid degradation modify the endocannabinoid system and redox balance in rat heart and plasma.
    Biernacki M; Malinowska B; Timoszuk M; Toczek M; Jastrząb A; Remiszewski P; Skrzydlewska E
    Prostaglandins Other Lipid Mediat; 2018 Sep; 138():54-63. PubMed ID: 30201316
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antidepressant-like effects of curcumin in chronic mild stress of rats: involvement of its anti-inflammatory action.
    Jiang H; Wang Z; Wang Y; Xie K; Zhang Q; Luan Q; Chen W; Liu D
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Dec; 47():33-9. PubMed ID: 23876788
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Enhancement of endocannabinoid signaling protects against cocaine-induced neurotoxicity.
    Vilela LR; Gobira PH; Viana TG; Medeiros DC; Ferreira-Vieira TH; Doria JG; Rodrigues F; Aguiar DC; Pereira GS; Massessini AR; Ribeiro FM; de Oliveira AC; Moraes MF; Moreira FA
    Toxicol Appl Pharmacol; 2015 Aug; 286(3):178-87. PubMed ID: 25933444
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis.
    Gobbi G; Bambico FR; Mangieri R; Bortolato M; Campolongo P; Solinas M; Cassano T; Morgese MG; Debonnel G; Duranti A; Tontini A; Tarzia G; Mor M; Trezza V; Goldberg SR; Cuomo V; Piomelli D
    Proc Natl Acad Sci U S A; 2005 Dec; 102(51):18620-5. PubMed ID: 16352709
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inhibition of endocannabinoid-degrading enzyme fatty acid amide hydrolase increases atherosclerotic plaque vulnerability in mice.
    Hoyer FF; Khoury M; Slomka H; Kebschull M; Lerner R; Lutz B; Schott H; Lütjohann D; Wojtalla A; Becker A; Zimmer A; Nickenig G
    J Mol Cell Cardiol; 2014 Jan; 66():126-32. PubMed ID: 24286707
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inhibition of fatty acid amide hydrolase (FAAH) reduces spinal nociceptive responses and expression of spinal long-term potentiation (LTP).
    Eriksen GS; Jacobsen LM; Mahmood A; Pedersen LM; Gjerstad J
    Brain Res Bull; 2012 Feb; 87(2-3):234-7. PubMed ID: 22133920
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Strain- and context-dependent effects of the anandamide hydrolysis inhibitor URB597 on social behavior in rats.
    Manduca A; Servadio M; Campolongo P; Palmery M; Trabace L; Vanderschuren LJ; Cuomo V; Trezza V
    Eur Neuropsychopharmacol; 2014 Aug; 24(8):1337-48. PubMed ID: 24933531
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.